Nasojejunal versus oral feeding after endoscopic drainage of walled-off pancreatic necrosis
Official title: Nasojejunal Feeding Versus Oral Feeding Following Endoscopic Drainage of Walled Off Pancreatic Necrosis: A Randomized Controlled Pilot Study
Run by Post Graduate Institute of Medical Education and Research, Chandigarh · NCT07395778 · Data updated 2026-11-12
This will see if feeding through a tube into the small intestine (nasojejunal feeding) works better than eating by mouth for adults undergoing endoscopic drainage of walled-off pancreatic necrosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Post Graduate Institute of Medical Education and Research, Chandigarh Academic / other |
| Locations | 1 site (Chandigarh) |
| Status | Recruiting |
| Started | October 18, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | January 2027 |
| Registry record updated | February 9, 2026 |
| Trial ID | NCT07395778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with symptomatic walled-off pancreatic necrosis who require EUS-guided transluminal drainage and can give informed consent are the intended participants.
✕Probably not a fit
Patients whose collections are not reachable by EUS, those with active GI bleeding or obstruction, major immunosuppression or malignancy, prior disruptive upper GI surgery, severe coagulopathy, pregnancy/lactation, or those too unstable for endoscopy are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center randomized trial at PGIMER Chandigarh compares nasojejunal tube feeding to oral feeding following endoscopic ultrasonography-guided cystogastrostomy for symptomatic walled-off pancreatic necrosis. Adult patients (18–75 years) who require EUS-guided transluminal drainage and can consent are randomized to one of the two nutritional strategies after the procedure. Key outcomes include infection rates, tube/feed tolerance, weight change, and need for reintervention. Patients with collections not amenable to EUS drainage, major comorbidities, active GI bleeding or obstruction, severe coagulopathy, pregnancy/lactation, or those who are moribund are excluded.
Why it matters
Potential benefit: If successful, the trial could identify a feeding approach that reduces infections and improves nutritional recovery after endoscopic drainage of walled-off pancreatic necrosis.
How similar studies have gone: Nasojejunal feeding has been used in severe acute pancreatitis and has supportive observational data, but direct randomized evidence specifically comparing nasojejunal versus oral feeding after endoscopic drainage of WON is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients of acute pancreatitis (AP) with 18-75 years of age 2. Patients with symptomatic WON requiring EUS guided transluminal drainage 3. Provision of written informed consent Exclusion Criteria: 1. Patients with collection not amenable for EUS guided drainage (distance of WON \>1 cm from the gastrointestinal lumen) 2. Known malignancy or immunocompromised state 3. Previous upper gastrointestinal(GI) surgery interfering with absorption 4. Active GI bleeding 5. GI obstruction, ileus or persistent vomiting 6. Patients moribund to undergo endoscopic procedure (Glasgow coma scale \<8 or patients on ventilatory support) 7. Patients with irreversible coagulopathy like platelets \<50,000/mm3 and/or INR\>1.5 8. Pregnant or lactating female
Where it's running
-
Post Graduate Institute of Medical Education and Research (PGIMER)
Chandigarh, India Recruiting
Study contacts
- Principal investigator: Surender Singh Rana, Professor — Post Graduate Institute of Medical Education and Research, Chandigarh
- Study coordinator: Saurabh Kumar Singh
- Email: drsaurabhkrsingh@gmail.com
- Phone: +919560113930
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stroke Volume–Based Fluid Resuscitation in Acute Pancreatitis
This trial tests whether adjusting IV fluids based on each patient’s stroke volume helps people with acute pancreatitis avoid fluid overload while staying well hydrated.
-
Early Upper GI Endoscopy in Acute Pancreatitis (ENDOPAN) - an observational study
This study tests whether early endoscopic findings in adults with acute pancreatitis relate to how severe their illness becomes.
-
Acute pancreatitis after percutaneous mechanical thrombectomy: a retrospective analysis
This project will look at adult medical records to see how often acute pancreatitis happens after percutaneous mechanical thrombectomy for thrombotic peripheral vascular disease.
-
AI-guided decision support for managing pancreatic conditions
This project will test an AI tool that reads contrast-enhanced CT scans to help doctors decide whether people with suspected pancreatic disease need surgery, close monitoring, or routine follow-up.
-
Using bowel sounds to predict severe acute pancreatitis
This study is testing if monitoring bowel sounds can help doctors predict which patients with acute pancreatitis might develop severe complications.
-
Combining Dextran 40 with Ringer's Lactate for treating Acute Pancreatitis
This study is testing if combining Dextran 40 with Ringer's lactate can help people with mild to moderate acute pancreatitis recover better and avoid serious complications compared to using Ringer's lactate alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.